• About Us
  • Advertise
  • Contact Us
  • DMCA
  • Privacy Policy
  • Follow on Google News
Saturday, July 5, 2025
  • Login
News Punjab
  • Home
  • Punjab
  • India
    • National
    • State News
  • World
  • Business
  • Education
  • Entertainment
  • Lifestyle
    • Health & Fitness
    • Fashion & Beauty
    • Travel
    • Food
    • Photography
  • Tech
    • App News
  • Auto
  • Sports
  • Finance/Money
  • Others
    • Agriculture
    • Science
    • Astrology
    • Press Release
    • Religion
    • Social Work
No Result
View All Result
  • Home
  • Punjab
  • India
    • National
    • State News
  • World
  • Business
  • Education
  • Entertainment
  • Lifestyle
    • Health & Fitness
    • Fashion & Beauty
    • Travel
    • Food
    • Photography
  • Tech
    • App News
  • Auto
  • Sports
  • Finance/Money
  • Others
    • Agriculture
    • Science
    • Astrology
    • Press Release
    • Religion
    • Social Work
No Result
View All Result
News Punjab
No Result
View All Result
Home Science

Blood-based biomarkers for brain tumours identified

by News Punjab Desk
November 22, 2021
in Science
Reading Time: 2 mins read
A A
0
Share on FacebookShare on Twitter

New Delhi, Nov 22: A study by researchers at the Indian Institute of Science (IISc), along with collaborators, has identified potential blood-based biomarkers to predict disease progression and survival times in those with late-stage brain tumours.

The team included researchers from the Centre for BioSystems Science and Engineering (BSSE) at IISc, the Mazumdar Shaw Centre for Translational Research and Mazumdar Shaw Medical Foundation. 

RELATED POSTS

Young Scientist R. Vishnu Prassad from Chennai conferred Times Award

Young Scientist R. Vishnu Prassad from Chennai conferred Times Award

July 4, 2022

Police to deploy more than 5,800 personnel for IMF-World

January 31, 2022

They analysed tumour and blood samples from individuals with gliomas – tumours that occur in the brain – to identify surface proteins on immune cells in the blood whose levels were closely linked to tumour progression.

“Our pilot study suggests that we can potentially use two blood-based biomarkers present on immune cells to identify patients who might not perform well with particular treatment strategies,” says Siddharth Jhunjhunwala, Assistant Professor in BSSE, and senior author of the study.

Conventional cancer treatments like chemotherapy are often ineffective in treating these tumours. This has prompted a shift to newer techniques like immunotherapy, which involves provoking the immune system of the patient to attack the tumour cells. However, attempts to use some of the standard immunotherapies to treat gliomas have met with limited success. The scientists were trying to address this gap by understanding the immune profile in the tumour microenvironment.

The team collected blood and tumour samples from patients with grade three and grade four gliomas and compared the numbers of specific immune cells called monocytes and neutrophils in these samples. 

The team also looked for differences in the composition of surface proteins on these cells across the two grades of tumours. They found that a certain type of monocytes — the M2 monocytes — were present in larger numbers in the samples from grade four tumours. Previous studies have shown that high numbers of M2 monocytes are associated with a suppression of immune responses, and the new finding could help develop new treatment strategies. “Future studies could focus on developing therapies that reduce the numbers of M2 monocytes in the tumour microenvironment or alter their functionality,” says Jhunjhunwala.

The researchers also found that levels of two surface proteins on neutrophils and monocytes, CD86 and CD63, were closely related in both the blood and tumour samples. The presence of high levels of these proteins on immune cells in other tumours has previously been associated with poor prognosis or low chances of survival. “What our study showed is that you do not need to look at these markers only in the tumours, you might be able to look at these just from the blood, and the clinician can make an assessment,” he says.

Jhunjhunwala said that further testing and validation is, however, needed on a larger scale before this can be taken from the lab to the clinic. “We would like to expand our cohort and test for only these two markers now, in individuals with stage three and stage four brain tumours and follow their survival times.”  (India Science Wire)

A report on the study has been published in OncoImmunology.

Tags: biomarkerblood samplebrain tumour Mazumdar Shaw Centre for Translational Researchcancerchemotherapydisease progressiongliomasIIScimmune cellimmunotherapyIndian Institute of ScienceMazumdar Shaw Medical Foundationmonocytesneutrophilssurface protein
ShareTweetShareSendSharePinSend
Previous Post

Surat based Singer – Songwriter Harshit Singh Baid drops his first original song ‘Kabhi Na Kabhi’

Next Post

Bird Group organizes a webinar to discuss initiatives to steer our industry towards growth and rebuild the future of travel

News Punjab Desk

News Punjab Desk

Related Posts

Young Scientist R. Vishnu Prassad from Chennai conferred Times Award

Young Scientist R. Vishnu Prassad from Chennai conferred Times Award

by News Punjab Desk
July 4, 2022
0

Scientist Vishnu Prassad Conferred with Times 40 under 40 - 2022 On 30th June 2022, Times 40 under 40 award...

Police to deploy more than 5,800 personnel for IMF-World

by News Punjab Desk
January 31, 2022
0

When we get out of the glass bottle of our ego and when we escape like the squirrels in the...

West Java to review Meykardah project amid alleged bribery case

by News Punjab Desk
January 30, 2022
0

Dropcap the popularization of the “ideal measure” has led to advice such as “Increase font size for large screens and...

Government targets 16.6% tax revenue growth in 2019

by News Punjab Desk
January 29, 2022
0

When we get out of the glass bottle of our ego and when we escape like the squirrels in the...

CSIR-IICT establishes new pilot plant facility

by News Punjab Desk
December 29, 2021
0

New Delhi, Dec. 29: A state-of-the-art Kilo Lab facility named after Acharya PC Ray has been set up at Council...

Next Post

Bird Group organizes a webinar to discuss initiatives to steer our industry towards growth and rebuild the future of travel

Your Guide To Nykaa’s Pink Friday Sale- The Year’s Biggest, Baddest & Boujeest Celebration Of Style

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Kingston Reinforces Legacy of Performance with Refreshed XS Series External SSD Lineup

Kingston Reinforces Legacy of Performance with Refreshed XS Series External SSD Lineup

June 26, 2025
Digital News Giant in the Making: Public Bytes TV on the Rise

Digital News Giant in the Making: Public Bytes TV on the Rise

June 7, 2025
Lotus Derma Botanics Enters the Skincare Arena

Lotus Derma Botanics Enters the Skincare Arena

May 28, 2025

Categories

  • Agriculture
  • App News
  • Astrology
  • Auto
  • Business
  • Education
  • Entertainment
  • Fashion & Beauty
  • Finance/Money
  • Food
  • Health & Fitness
  • India
  • Lifestyle
  • National
  • Photography
  • Politics
  • Press Release
  • Punjab
  • Religion
  • Science
  • Social Work
  • Sports
  • State News
  • Tech
  • Travel
  • World
  • About Us
  • Advertise
  • Contact Us
  • DMCA
  • Privacy Policy
  • Follow on Google News

© 2022 News Punjab

No Result
View All Result
  • About Us
  • Advertise
  • Contact Us
  • DMCA
  • Home
  • Privacy Policy

© 2022 News Punjab

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In